Activation of the caspase proteases by c-Jun N-terminal kinase 1 (JNK1
) has been proposed as a mechanism of apoptotic cell death. Here we re
port that insulin activates caspase-3 by a pathway requiring phosphati
dylinositol 3'-kinase (PI3-kinase). JNK1 assays demonstrated that insu
lin treatment of myeloma cells induced 3-fold activation of JNK1. Inhi
bition of PI3-kinase with wortmannin and LY294002 blocked insulin-depe
ndent activation of JNK1. Caspase assays demonstrated that insulin inc
reased caspase-3 activity 3-fold and that inhibition of PI3-kinase bla
cked this effect. Cell death was doubled by insulin and was due to a 3
-fold increase in apoptosis of cells in the G1/G0 phase of the cell cy
cle. Inhibition of PI3-kinase completely blocked this effect. Finally,
inhibition of caspase-3 with oxycarbonyl-Asp-2,6-dichlorobenzoyloxyme
thylketone blocked cell death due to insulin. Taken together, these fi
ndings indicate that insulin activates caspase-3 by a PI3-kinase-depen
dent pathway resulting in increased apoptosis and cell death. (C) 1998
Elsevier Science Inc.